ISEE — IVERIC bio Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
U.S. STOCKS ON THE MOVE-Grindr, Utilities, StoneCo, Carvana
U.S. STOCKS ON THE MOVE-Foot Locker, Applied Materials, Iveric
Iveric soars as eye drug gets FDA's 'breakthrough therapy' tag
Brief: Iveric Bio Announces FDA Has Granted Therapy Designation For Avacincaptad Pegol
Brief: Iveric Bio Announces Submission Of First Part Of NDA For Rolling Review Of Avacincaptad Pegol For The Treatment Of Geographic Atrophy
Iveric to seek FDA approval for drug ahead of schedule; shares up
Iveric Bio Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: Iveric Bio Reports Q3 Loss Of 35 Cents Per Share
Iveric Bio Inc Expected To Post A Loss Of 40 Cents A Share: Earnings Preview
U.S. RESEARCH ROUNDUP- Domino's Pizza, Juniper Networks, Walmart
Brief: IVERIC Bio To Present Top-Line Results For Avacincaptad Pegol From Phase 3 Gather2 Clinical Trial In Geographic Atrophy At Aao 2022 Annual Meeting
U.S. RESEARCH ROUNDUP-Golden Entertainment, Red Rock Resorts, Signify Health
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
U.S. STOCKS ON THE MOVE-UiPath, FedEx, Iveric Bio, miners
Brief: Iveric Bio Announces Positive Topline Data From Zimura® Gather2 Phase 3 Clinical Trial In Geographic Atrophy
Iveric Bio soars after eye drug meets main goal in late-stage study
Iveric Bio Inc Reports Results For The Quarter Ended In June: Earnings Summary